Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04549701
Other study ID # 090920
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 20, 2022
Est. completion date February 28, 2023

Study information

Verified date May 2024
Source Instituto Cardiovascular de Buenos Aires
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Between 25% and 30% of patients hospitalized for acute heart failure (AHF) are readmitted within 90 days after discharge. Mostly due to persistent congestion on discharge. However, as the optimal evaluation of decongestion is not clearly defined, it is necessary to implement new tools to identify subclinical congestion to guide treatment.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date February 28, 2023
Est. primary completion date January 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Hospitalization of 24 hours or greater for decompensated heart failure defined as new-onset of symptoms or worsening of previous symptoms (including orthopnea, progression to FC III-IV, bendopnea or fatigue) or signs of volume overload. and - Jugular venous distension, hepatojugular reflux, lower extremity edema or signs of pulmonary congestion. and - Chest X-ray with signs suggestive of pulmonary congestion. and - Elevated ´pro-B-type natriuretic peptide (NT-proBNP) levels of 450 pg/mL, 900 pg/mL, and 1800 pg/mL for ages < 50 years, 50 to 75 years, and > 75 years, respectively, within 24 hours of admission (53,54). and - Sufficient ultrasound visualization to assess IVC and lungs. Exclusion Criteria: - Not willing to participate. - Life expectancy of less than 6 months. - Uninterpretable lung or inferior vena cava ultrasound. - Transfer to another hospital before hospital discharge. - SBP < 90 mm Hg. - Chronic kidney disease (creatinine clearance <30 mL/min calculated with the MDRD equation or hemodialysis). - Requirement for invasive or noninvasive ventilator support. - Pregnancy. - Low cardiac output syndrome/cardiogenic shock. - Death during index hospitalization. - Acute coronary syndrome, myocardial revascularization or heart valve replacement within the previous 3 months. - Being on heart transplant waiting list. - Cardiac resynchronization therapy device implanted within the previous 3 months. - Severe tricuspid valve regurgitation. - Heart failure secondary to causes amenable to invasive correction: cardiac surgery, percutaneous interventions or pacemaker implantation. - Heart failure secondary to significant arrhythmias (advanced atrioventricular block or sinus arrest, sustained ventricular tachycardia or any sustained arrhythmia other than atrial fibrillation causing hemodynamic instability according to the discretion of the treating physician). - Heart failure secondary to severe systemic infection - Severe psychiatric illness - Palliative care - SARS-CoV-2 infection

Study Design


Related Conditions & MeSH terms


Intervention

Other:
CAVAL US-guided Therapy
Patients randomly assigned to this group will receive a daily CAVAL US exam guided decongestive therapy accessible to treating medical team, in addition to the standard care.
Standard of care
Standard of care will be provided.

Locations

Country Name City State
Argentina Instituto Cardiovascular de Buenos Aires Buenos Aires Buenos Aires City
Argentina Instituto Cardiovascular de Buenos Aires Buenos Aires Ciudad Autónoma De Buenos Aires

Sponsors (1)

Lead Sponsor Collaborator
Instituto Cardiovascular de Buenos Aires

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subclinical congestion at discharge Discharge
Secondary Readmission for heart failure, unplanned visit for worsening HF, or death. Readmission for heart failure: unscheduled urgent hospital visit and stay longer than 24 hours, requiring medical interventions.
Mortality: death of the patient. Unplanned visit for worsening heart failure: unscheduled visit to the emergency department that led to an increase in oral / intravenous therapy, stay less than 24 hours.
90 days
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy